Benjamin L. Oakes
Vorstandsvorsitzender bei Scribe Therapeutics, Inc.
Aktive Positionen von Benjamin L. Oakes
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Präsident | - | - |
Karriereverlauf von Benjamin L. Oakes
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Chief Executive Officer | 1 |
| Founder | 1 |
| President | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Scribe Therapeutics, Inc. engages in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Berkeley, CA. | Health Technology |
- Börse
- Insiders
- Benjamin L. Oakes
- Erfahrung
